RVMD

Revolution Medicines, Inc.NASDAQHealthcare

$99.12+0.49%ClosedMarket Cap: $19.64B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-26	Piper Sandler	—	Overweight	—
2026-02-26	Wells Fargo	—	Overweight	—
2026-02-26	Needham	—	Buy	—
2026-02-02	JP Morgan	—	Overweight	—
2026-01-27	Oppenheimer	—	Outperform	—
2026-01-22	Stifel	—	Buy	—
2026-01-21	RBC Capital	—	Outperform	—
2026-01-20	Guggenheim	—	Buy	—
2026-01-13	Mizuho	—	Outperform	—
2026-01-09	Wedbush	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-6.77	$374.3M	15
Sun Dec 31	$-4.61	$981.3M	13
Mon Dec 31	$-0.43	$2.09B	11
Tue Dec 31	$5.22	$3.68B	5

RVMD | Revolution Medicines, Inc. Analyst Ratings & Price Target - InvestLog